全文获取类型
收费全文 | 23581篇 |
免费 | 1158篇 |
国内免费 | 762篇 |
专业分类
耳鼻咽喉 | 103篇 |
儿科学 | 112篇 |
妇产科学 | 213篇 |
基础医学 | 4696篇 |
口腔科学 | 221篇 |
临床医学 | 992篇 |
内科学 | 2676篇 |
皮肤病学 | 245篇 |
神经病学 | 5733篇 |
特种医学 | 270篇 |
外国民族医学 | 1篇 |
外科学 | 1011篇 |
综合类 | 1561篇 |
现状与发展 | 3篇 |
预防医学 | 311篇 |
眼科学 | 167篇 |
药学 | 6006篇 |
中国医学 | 246篇 |
肿瘤学 | 934篇 |
出版年
2023年 | 108篇 |
2022年 | 174篇 |
2021年 | 365篇 |
2020年 | 331篇 |
2019年 | 357篇 |
2018年 | 349篇 |
2017年 | 409篇 |
2016年 | 405篇 |
2015年 | 508篇 |
2014年 | 824篇 |
2013年 | 1269篇 |
2012年 | 884篇 |
2011年 | 1153篇 |
2010年 | 966篇 |
2009年 | 1132篇 |
2008年 | 1241篇 |
2007年 | 1078篇 |
2006年 | 1026篇 |
2005年 | 940篇 |
2004年 | 936篇 |
2003年 | 874篇 |
2002年 | 714篇 |
2001年 | 602篇 |
2000年 | 555篇 |
1999年 | 479篇 |
1998年 | 612篇 |
1997年 | 591篇 |
1996年 | 505篇 |
1995年 | 477篇 |
1994年 | 459篇 |
1993年 | 415篇 |
1992年 | 380篇 |
1991年 | 347篇 |
1990年 | 307篇 |
1989年 | 305篇 |
1988年 | 233篇 |
1987年 | 258篇 |
1986年 | 237篇 |
1985年 | 415篇 |
1984年 | 514篇 |
1983年 | 320篇 |
1982年 | 403篇 |
1981年 | 307篇 |
1980年 | 232篇 |
1979年 | 171篇 |
1978年 | 105篇 |
1977年 | 82篇 |
1976年 | 63篇 |
1975年 | 27篇 |
1974年 | 25篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
用苔盼蓝及吖啶橙染色,DNA片段检定与DNA电泳等方法进行组织胺诱导胸腺细胞凋亡的研究,旨在探讨其可能机制及其在胸腺细胞负选择中的作用。结果表明,组织胺诱导使体外培养的胸腺细胞出现典型的细胞调亡。雷尼替丁可阻断上述作用,提示胸腺细胞存在H_2受体,活化该受体可能在胸腺细胞的负选择中起重要作用。 相似文献
72.
In this study, the behavioural response to dopamine D1-like receptor agonists (SKF 38393, SKF 81297 and SKF 77434) and D2-like receptor agonists (quinpirole and RU 24213), administered alone and in combination to rats treated repeatedly with electroconvulsive
shock (five ECS over 10 days) or sham, was tested. Agonist-induced behaviour was monitored by automated activity meters and
direct observation using a checklist scoring method. Repeated ECS (compared to sham controls) had no significant effect on
the behavioural response to SKF 38393 (7.5 mg/kg SC), SKF 81297 (0.2 mg/kg SC), SKF 77434 (0.1 mg/kg SC), quinpirole (0.1
and 0.25 mg/kg SC) or RU 24213 (0.3 mg/kg SC), when administered alone. In contrast, repeated ECS markedly increased locomotion
(activity counts and scores) induced by the non-selective dopamine agonist apomorphine (0.5 mg/kg SC) and by co-administration
of a D1-like agonist plus a D2-like agonist [SKF 38393 (7.5 mg/kg SC) plus quinpirole (0.25 mg/kg SC), SKF 81297 (0.2 mg/kg SC) plus quinpirole (0.1 mg/kg
SC), and SKF 77434 (0.1 mg/ kg SC) plus RU 24213 (0.3 mg/kg SC)]. This ECS-induced enhancement of dopamine-mediated behaviour
was observed for up to 3 weeks after cessation of ECS treatment. In addition, ECS also enhanced the locomotor response to
intra-accumbens SKF 38393 plus quinpirole (0.4 and 1.0 μg/side, respectively). These results provide evidence that the enhancement
of dopamine function by repeated ECS requires concomitant stimulation of both D1-like and D2-like receptors, and that this effect is long-lasting.
Received: 24 January 1997 /Final version: 5 March 1997 相似文献
73.
Summary. Platelet membranes provide procoagulant surfaces for the assembly and expression of the factor X-activating complex and promote the proteolytic activation and assembly of the prothrombinase complex resulting in normal hemostasis. Recent studies from our laboratory and others indicate that platelets possess specific, high-affinity, saturable, receptors for factors XI, XIa, IX, IXa, X, VIII, VIIIa, V, Va and Xa, prothrombin, and thrombin. Studies described in this review support the hypothesis that the factor X-activating complex on the platelet surface consists of three receptors (for the enzyme, factor IXa; the substrate, factor X; and the cofactor, factor VIIIa), the colocalization of which results in a 24 million-fold acceleration of the rate of factor X activation. Whether the procoagulant surface of platelets is defined exclusively by procoagulant phospholipids, or whether specific protein receptors exist for the coagulant factors and proteases, is currently unresolved. The interaction between coagulation proteins and platelets is critical to the maintenance of normal hemostasis and is pathogenetically important in human disease. 相似文献
74.
75.
76.
P. E. Marchiori M. dos Reis M. E. Quevedo M. Scaff W. Cossermelli J. L. Assis R. M. de Oliveira 《Acta neurologica Scandinavica》1989,80(5):387-389
Radioimmunoassay techniques were used to detect antibodies to the acetylcholine receptor (AAChR) in 164 patients with adult-onset myasthenia gravis. AAChR levels above 0.6 nM/l were considered pathological and were found in 67% of the patients with an average value of 58.99 +/- 125.02 nM/l (0.6-900.0). Correlation, with clinical functional status, the histopathological thymus alterations and the different therapeutics used did not disclose any statistically significant differences. 相似文献
77.
Per Hartvig S.Å. Eckernäs Leif Lindström Bengt Ekblom Ulf Bondesson Hans Lundqvist Christer Halldin Kjell Någren Bengt Långström 《Psychopharmacology》1986,89(2):248-252
By means of positron emission tomography the uptake and kinetics of N-(methyl-11C)clozapine in different brain regions have been studied in Rhesus monkeys. 11C-clozapine rapidly entered the brain and maximum radioactive uptake was seen 5–12 min after administration. Highest uptake was measured in the striatum. Other regions with an uptake higher than in the cerebellum were thalamus and mesencephalon. The radioactivity from different brain regions decreased with an elimination half-life of about 5 h and parallelled the plasma kinetics of unlabelled clozapine. The striatum/cerebellum ratio of 11C-clozapine-derived radioactivity remained constant during the period studied and did not change after pretreatment with atropine. In contrast, the striatum/cerebellum ratio was somewhat lower after pretreatment with N-methylspiperone (NMSP), indicating competition for the same binding sites in the striatum. After pretreatment with increasing doses of clozapine, a dose-dependent protection of binding sites in the striatum for 11C-NMSP was seen. It is concluded that clozapine is more loosely bound to dopamine receptors in the striatum than N-methylspiperone and that the kinetics of clozapine in the brain parallel that in the plasma. The binding properties of clozapine within the brain may explain some of the clinical properties of the drug. 相似文献
78.
本文从下丘脑、大脑皮层、海马等脑区去甲肾上腺素(NA)的含量,其合成酶与降解酶的活性、NA受体数目等多环节的测定来分析肾上腺素能神经递质系统在老化脑中的变化。实验结果表明衰老过程下丘脑、大脑皮层内NA合成酶活性没变化,NA含量明显增高,下丘脑内α_1受体数目显著减少。上述结果提示这些脑区肾上腺素能神经的活动有可能减弱。同时,海马内单胺氧化酶B(MAO B)活性明显增加,说明海马神经元外组织有增生的可能。泰文并讨论了这些变化与老年记忆、行为与神经内分泌等脑功能衰退的关系。 相似文献
79.
G. D'Agostino M. C. Chiari E. Grana 《Naunyn-Schmiedeberg's archives of pharmacology》1989,340(1):76-81
Summary The inhibitory effects of some muscarinic agonists on tritiated acetylcholine release evoked by field stimulation were investigated in the rat urinary bladder strip. The acetylcholine stores of the preparation were labelled with 3H-choline. Electrical field stimulation caused an outflow of tritium, reflecting the release of 3H-acetylcholine. The release of 3H-acetylcholine was decreased in a concentration-dependent manner by all the agonists tested: oxotremorine, muscarone, muscarine, carbachol and methylfurtrethonium. On the contrary, only muscarine and muscarone enhanced the basal efflux of tritium in a concentration-dependent fashion. Concentration-response curves were determined both at 2 Hz and at 1 Hz by using intermittent administration of the drugs. Maximal depression in release (by 78 – 82%) was observed in experiments at 1 Hz. A similar inhibition was obtained at 2 Hz frequency only when a low concentration of calcium (0.6 mM) in the medium was used. Oxotremorine was the most potent among the tested compounds with the same intrinsic activity as the other drugs. In contrast to the other agonists investigated, oxotremorine showed in about 10-fold greater potency at pre- than at postjunctional muscarine receptors in the rat urinary bladder. This difference might depend either on heterogeneity of muscarine receptors or on different mechanism(s) relating to the transducing properties of receptors at the pre- and postjunctional level. A comparison between the relative prejunctional potencies in the rat urinary bladder and in the guinea pig myenteric plexus (data from the literature) suggests that prejunctional muscarine receptors are similar in these tissues. Furthermore, the findings obtained with a low concentration of calcium in the medium may support the view that intraneuronal availability of calcium plays a significant role in modulating the prejunctional negative feed-back mechanism in the rat urinary bladder.Send offprint requests to Dr. G. D'Agostino at the above address 相似文献
80.
B. BEGAUD L. DANG TRAN J.L. MONTASTRUC and P. MONTASTRUC 《Fundamental & clinical pharmacology》1987,1(3):153-159
The cardiovascular effects of mesulergine were studied in anesthetized dogs. Intravenous (IV) administration (0.3 mg/kg) significantly decreased blood pressure in neurogenic hypertensive dogs without any change in heart rate. This effect was completely antagonized by IV administration of domperidone (0.5 mg/kg). Intracisternal administration of mesulergine (0.03, 0.3 and 3 mg/kg) did not produce any change in blood pressure. However, with the highest dose we observed a significant rise in heart rate during the first 2 min (which was probably nonspecific). These results suggest that mesulergine lowers blood pressure in sinoaortic-denervated dogs by means of a peripheral mechanism probably involving DA2 receptors. The findings confirm the potential interest of dopamine-receptor agonists as future antihypertensive agents. 相似文献